Skip to content

In Vitro Analysis of Human Urine With the CloudCath Device

In Vitro Analysis of Human Urine With the CloudCath Device

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04950582
Enrollment
500
Registered
2021-07-06
Start date
2021-06-04
Completion date
2024-06-15
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections

Brief summary

This is a multi-center feasibility study to assess the in vitro function of the CloudCath Device that is being developed to derive clinically-relevant information from the optical characteristics of urine.

Detailed description

Specimens will be obtained from participants with indwelling catheters in hospital or home settings, who are suspected to be at high risk for urinary tract infection. To evaluate the performance of the CloudCath Device in repeated measurements over time, multiple specimens may be obtained from the same patients over multiple days or months. Each sample will be divided into multiple aliquots. One part will be analyzed using the CloudCath Device and reference devices. Another part may be submitted to an independent lab for standard analytical tests.

Interventions

DIAGNOSTIC_TESTSpectral characteristics assessment

Urine sample analysis for evidence of urinary tract infection

Sponsors

CloudCath
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* provide a signed informed consent * patient has an implanted urinary catheter (i.e., Foley, Texas, ureteral)

Exclusion criteria

* any condition that the investigator feels may confound the study results or place the participant at risk by participating in the study * currently taking antibiotics for any reason other than for treatment of urinary tract infection (UTI) * suprapubic bladder catheter implanted

Design outcomes

Primary

MeasureTime frameDescription
Spectral characteristics of urine specimensDuring the period of time that the patient is catheterized (expected to be up to ~1 week)A quantitative analysis of the spectral properties of the urine specimen using a proprietary algorithm that results in a quantitative CloudCath Turbidity Score (0-100, with higher values indicating more turbidity).

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026